# Future oncology

Source: https://onco.cc/journals/future-oncology/  
OnCo record `future-oncology` (Journal). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A high-frequency clinical oncology journal formerly from Future Medicine and now published by Taylor & Francis. It carries trial protocols, reviews and original research and is read by clinical oncologists and industry researchers.

## Summary

Future Oncology is published by Taylor & Francis (Informa UK). The NLM Catalog records that it began in 2005 in London with Future Medicine Ltd, moved to Taylor & Francis in 2024, increased from thirty-six issues a year (2019 to 2021) to forty issues a year from 2022, and is indexed in MEDLINE with content deposited in PubMed Central. Crossref lists Informa UK (Taylor & Francis) as publisher.

## Fields

- Kind: Journal
- Last checked: 2026-09-10
- Also known as: Future Oncol
- Publisher: Taylor & Francis
- Scope: clinical oncology

## Sources

- Homepage: https://www.tandfonline.com/journals/ifon
- NLM Catalog: https://www.ncbi.nlm.nih.gov/nlmcatalog/101256629

## Connected records

- collections: [PubMed & Europe PMC](https://onco.cc/collections/pubmed-europepmc/)
- people: [Neeraj Agarwal](https://onco.cc/people/neeraj-agarwal/), [Sara López-Tarruella](https://onco.cc/people/sara-lopez-tarruella/), [Taofeek K. Owonikoko](https://onco.cc/people/taofeek-owonikoko/)
- key papers: [KRYSTAL-12 plain language summary: adagrasib for non-small-cell lung cancer with KRAS G12C mutations](https://onco.cc/key-papers/paper-krystal-12-plain-language-summary-future-oncol-2026/)

---
JSON: https://onco.cc/api/v1/entities/future-oncology.json